Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial

Martyn Thomas1*, MD; Christoph A. Nienaber2, MD; Hüseyin Ince2, MD, PhD; Andrejs Erglis3, MD, PhD; Vladan Vukcevic4, MD; Ulrich Schäfer5, MD; Rui Cruz Ferreira6, MD; Stefan Hardt7, MD; Stefan Verheye8, MD, PhD; Vasco Gama Ribeiro9, MD; Lissa Sugeng10, MD, MPH; Corrado Tamburino11, MD

1. St. Thomas’ Hospital, London, United Kingdom; 2. University of Rostock, Rostock, Germany; 3. Pauls Stradins Clinical University Hospital, Riga, Latvia; 4. Clinical Center of Serbia, Belgrade, Serbia; 5. Asklepios Klinik St. Georg, Hamburg, Germany; 6.

Aims: This prospective, non-randomised, observational study conducted in Europe was designed in order to assess the long-term safety and efficacy of the Parachute device in ischaemic hear

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

ischaemic heart failureleft ventricle remodellingstructural heart

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Getting maximum information out of a continuous outcome: applying linear regression